Xcell Therapeutics Inc. (KOSDAQ:373110)
South Korea · Delayed Price · Currency is KRW 998.00
-2.00 (-0.20%)
Sep 22, 2026, 3:30 PM KST
Xcell Therapeutics Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 3,928 | 2,094 | 7,764 | 1,239 | 5,436 | 14,632 |
Short-Term Investments | 300 | 300 | 35.67 | 120 | 120 | - |
Trading Asset Securities | - | 4,512 | 1,002 | - | - | - |
Cash & Short-Term Investments | 4,228 | 6,906 | 8,802 | 1,359 | 5,556 | 14,632 |
Cash Growth | 15.68% | -21.54% | 547.78% | -75.55% | -62.03% | 119.39% |
Accounts Receivable | 151.35 | -114.09 | 54.71 | 282.87 | 264.4 | 159.42 |
Other Receivables | 335.72 | 476.74 | 455.24 | 333.93 | 368.52 | 109.59 |
Receivables | 487.06 | 362.65 | 509.96 | 616.8 | 632.92 | 269.01 |
Inventory | 1,064 | 1,327 | 697.92 | 804.25 | 686.9 | 500.67 |
Prepaid Expenses | - | 322.31 | 10.6 | - | - | - |
Other Current Assets | 818.99 | 718.66 | 491.19 | 60.41 | 339.89 | 22.45 |
Total Current Assets | 6,598 | 9,637 | 10,512 | 2,840 | 7,216 | 15,425 |
Property, Plant & Equipment | 4,351 | 4,193 | 4,472 | 5,355 | 7,372 | 7,515 |
Long-Term Investments | 698.44 | 879.6 | 1,099 | 34.78 | 31.69 | 19.81 |
Other Intangible Assets | 650.56 | 694.06 | 537.35 | 125.05 | 307.51 | 238.75 |
Long-Term Accounts Receivable | 0 | -0 | -0 | -0 | -0 | -0 |
Other Long-Term Assets | 330.33 | 317.7 | 269.81 | 2,113 | 582.39 | 503.45 |
Total Assets | 12,628 | 15,721 | 16,890 | 10,468 | 15,509 | 23,702 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 290.8 | 217.14 | 125.57 | 133.66 | 90 | 227.29 |
Accrued Expenses | 235.23 | 344.28 | 295.36 | 263.38 | 277.52 | 244.79 |
Short-Term Debt | 3,500 | 3,500 | 3,500 | 4,000 | 4,000 | 4,000 |
Current Portion of Long-Term Debt | 116.64 | 116.64 | 87.56 | 72.5 | - | - |
Current Portion of Leases | 522.85 | 447.59 | 465.62 | 589.68 | 449.1 | 453.31 |
Other Current Liabilities | 496.64 | 706.2 | 432.39 | 383.32 | 370.56 | 332.31 |
Total Current Liabilities | 5,162 | 5,332 | 4,906 | 5,443 | 5,187 | 5,258 |
Long-Term Debt | 957.48 | 1,016 | 1,132 | 1,148 | 870 | 870 |
Long-Term Leases | 286.88 | 406.73 | 515.99 | 695.9 | 527.77 | 868.12 |
Pension & Post-Retirement Benefits | 1,218 | 1,130 | 693.4 | 288.17 | - | 93.87 |
Other Long-Term Liabilities | 677.38 | 699.43 | 520.26 | 510.64 | 440.67 | 387.31 |
Total Liabilities | 8,302 | 8,583 | 7,769 | 8,085 | 7,026 | 7,477 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 8,647 | 8,647 | 5,459 | 4,582 | 4,380 | 4,376 |
Additional Paid-In Capital | 64,647 | 64,140 | 57,993 | 42,711 | 39,913 | 39,860 |
Retained Earnings | -70,226 | -66,666 | -55,717 | -46,071 | -36,835 | -28,407 |
Comprehensive Income & Other | 1,258 | 1,017 | 1,386 | 1,162 | 1,025 | 395.85 |
Total Common Equity | 4,327 | 7,138 | 9,121 | 2,384 | 8,483 | 16,225 |
Shareholders' Equity | 4,327 | 7,138 | 9,121 | 2,384 | 8,483 | 16,225 |
Total Liabilities & Equity | 12,628 | 15,721 | 16,890 | 10,468 | 15,509 | 23,702 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 5,384 | 5,487 | 5,702 | 6,506 | 5,847 | 6,191 |
Net Cash (Debt) | -1,155 | 1,419 | 3,100 | -5,147 | -290.75 | 8,441 |
Net Cash Growth | - | -54.22% | - | - | - | 378.96% |
Net Cash Per Share | -77.92 | 121.82 | 309.85 | -581.98 | -33.21 | 1019.25 |
Filing Date Shares Outstanding | 17.29 | 17.29 | 10.92 | 9.16 | 8.76 | 8.75 |
Total Common Shares Outstanding | 17.29 | 17.29 | 10.92 | 9.16 | 8.76 | 8.75 |
Working Capital | 1,436 | 4,305 | 5,605 | -2,602 | 2,029 | 10,167 |
Book Value Per Share | 250.17 | 412.74 | 835.38 | 260.10 | 968.50 | 1854.01 |
Tangible Book Value | 3,676 | 6,444 | 8,584 | 2,258 | 8,176 | 15,986 |
Tangible Book Value Per Share | 212.55 | 372.61 | 786.16 | 246.46 | 933.39 | 1826.73 |
Land | 673.6 | 370.53 | 370.53 | 370.53 | 1,971 | 1,971 |
Buildings | 1,515 | 1,624 | 1,624 | 1,624 | 1,624 | 1,624 |
Machinery | 1,091 | 3,642 | 3,320 | 3,059 | 2,952 | 2,433 |
Construction In Progress | - | - | - | - | - | 278.4 |